KLAR — Klaria Pharma Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK123.23m
- SEK124.47m
- SEK8.99m
Brief: Klaria Q4 Net Income SEK -15.6 Million
Brief: Klaria Signs License Agreement For Sumatriptan Alginate Film In Europe With CNX Therapeutics
Brief: Klaria Q3 EPS at SEK -0.06
Brief: Klaria Pharma Decides On Set-Off Issue Of SEK 6 Mln Towards Creditors
Brief: Klaria Q2 Adjusted Free Cash Flow SEK -2 Million
Brief: Klaria Sumatriptan Alginate Film Receives Marketing Authorization
Brief: Klaria Q1 Net Income SEK -11.9 Million
Brief: Klaria Pharma Q4 Net Loss Narrows To SEK 7.9 Mln
Brief: Klaria Q3 Net Income SEK -10.8 Million
Brief: Klaria CEO Jesper Wiklund Leaves Company
Brief: Klaria Q2 EPS at SEK -0.09
Brief: Klaria Q1 Sales at SEK 6.5 Million
Brief: The Swedish Financial Supervisory Authority Initiates Investigation Of Klaria Pharma's Handling And Disclosing Of Inside Information
Brief: Klaria Receives SEK 2.6 Mln Funding
Brief: Klaria Q4 Net Loss SEK 12.9 Million
Brief: Klaria Pharma Raises SEK 59.2 Mln Before Issue Costs Through Rights Issue
Brief: Klaria Publishes Prospectus Relating To The Rights Issue And Gives Update Regarding Level Of Undertaking Of Rights Issue
Brief: Klaria Pharma Q3 Loss After Tax SEK 16.1 Mln
Brief: Klaria Pharma Holding Signs Agreement With PharmaMar